Healthcare • Biotechnology
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if BMEA is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
11 top institutions tracked
Last 13F trend: unchanged (light)
Unlock crowding heatmapUnlock filer discoverySentiment: unknown
No recent insider trades detected.
Red flags: 1
60 filers reported a long position in BMEA for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| FMR LLC | $13M | 8.8M | 0% |
| VANGUARD CAPITAL MANAGEMENT LLC | $4.2M | 2.8M | +9% |
| MARSHALL WACE, LLP | $3M | 2M | +71% |
| Aisling Capital Management LP | $3M | 2M | Unchanged |
| RENAISSANCE TECHNOLOGIES LLC | $2.1M | 1.5M | +10.9% |
| FIDEURAM - INTESA SANPAOLO PRIVATE BANKING S.P.A. | $1.1M | 723.2K | +29.8% |
| BlackRock, Inc. | $1.1M | 715.4K | +11.5% |
| GEODE CAPITAL MANAGEMENT, LLC | $1M | 708.9K | +29.3% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $900.7K | 612.7K | -2.7% |
| Mariner, LLC | $874.2K | 594.7K | -9.1% |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.